SWOT Analysis for Mono Pharmacare Ltd.

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Rising Net Cash Flow and Cash from Operating activity
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Weak Momentum: Price below Short, Medium and Long Term Averages
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter

Rising Delivery Percentage Compared to Prev Day

Mono Pharmacare Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats